Moon, Chansoo <br/><br/>
Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.  [electronic resource] 

 -  Digestive diseases and sciences  Feb 2015 
 - 573-81 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-014-3361-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Biomarkers--blood<br/>Carcinoma, Hepatocellular--diagnosis<br/>Chi-Square Distribution<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Incidence<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Kaplan-Meier Estimate<br/>Liver Cirrhosis--diagnosis<br/>Liver Neoplasms--diagnosis<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Polyethylene Glycols--adverse effects<br/>Protective Factors<br/>RNA, Viral--blood<br/>Recombinant Proteins--adverse effects<br/>Republic of Korea--epidemiology<br/>Retrospective Studies<br/>Ribavirin--adverse effects<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load